Ian William David Clements
Directeur/Membre du Conseil chez StemBioSys, Inc.
Profil
Ian William David Clements founded ViroXis Corp.
in 2006, where he worked as President & Chief Executive Officer.
Mr. Clements also founded C2xl Corp., where he worked as Chief Executive Officer.
Mr. Clements also currently works at StemBioSys, Inc., as Director, CytoBioscience, Inc., as Director, and Incyte Venture Partners LLC, as Managing Partner.
Mr. Clements also formerly worked at InventaBiotech, Inc., as Director, The Upjohn Co., as Head-Global Oncology Product Management, ILEX Oncology, Inc., as Head-Commercial Operations & Corporate Development, Novartis AG, as Principal, and Lederle Laboratories, as Head-Oncology Product Management.
Mr. Clements received his undergraduate degree from Swansea University and graduate degree from King's College London.
Postes actifs de Ian William David Clements
Sociétés | Poste | Début |
---|---|---|
StemBioSys, Inc.
StemBioSys, Inc. BiotechnologyHealth Technology StemBioSys, Inc. develops stem cell technologies. The firm develops technology on the isolation and expansion of specialized adult stem cells for clinical use. Its technology is called XC-marrowECM, which is a patented extracellular matrix laid down by human bone marrow mesenchymal stem cells. The company was founded by Xiao-Dong Chen and Steven A. Davis in 2010 and is headquartered in San Antonio, TX. | Directeur/Membre du Conseil | - |
CytoBioscience, Inc.
CytoBioscience, Inc. Medical SpecialtiesHealth Technology CytoBioscience, Inc. manufactures medical devices. It creates and manufactures devices that represent a convergence of bioscience, nano science, microchip development, algorithms and engineering. The firm offers CRO services. The company is headquartered in San Antonio, TX. | Directeur/Membre du Conseil | - |
Incyte Venture Partners LLC
Incyte Venture Partners LLC Investment ManagersFinance Incyte Venture Partners LLC (Incyte Venture Partners) is a venture capital firm founded in 2009. The firm is headquartered in San Antonio, Texas. | Private Equity Investor | - |
Anciens postes connus de Ian William David Clements
Sociétés | Poste | Fin |
---|---|---|
C2xl Corp. | Directeur Général | - |
INVENTABIOTECH INC. | Directeur/Membre du Conseil | - |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Corporate Officer/Principal | - |
NOVARTIS AG | Corporate Officer/Principal | - |
Lederle Laboratories
Lederle Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Lederle Laboratories is a company that provides testing services. The company is based in Pearl River, NY. | Corporate Officer/Principal | - |
Formation de Ian William David Clements
Swansea University | Undergraduate Degree |
King's College London | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
NOVARTIS AG | Health Technology |
Entreprise privées | 9 |
---|---|
ViroXis Corp.
ViroXis Corp. BiotechnologyHealth Technology ViroXis Corp. develops and commercializes bio-pharmaceuticals derived from sandalwood oils for viral diseases. The company was founded in 2006 by Ian William David Clements and Paul Castella and is headquartered in San Antonio, TX. | Health Technology |
The Upjohn Co. | Health Technology |
Lederle Laboratories
Lederle Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Lederle Laboratories is a company that provides testing services. The company is based in Pearl River, NY. | Commercial Services |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Health Technology |
C2xl Corp. | |
StemBioSys, Inc.
StemBioSys, Inc. BiotechnologyHealth Technology StemBioSys, Inc. develops stem cell technologies. The firm develops technology on the isolation and expansion of specialized adult stem cells for clinical use. Its technology is called XC-marrowECM, which is a patented extracellular matrix laid down by human bone marrow mesenchymal stem cells. The company was founded by Xiao-Dong Chen and Steven A. Davis in 2010 and is headquartered in San Antonio, TX. | Health Technology |
CytoBioscience, Inc.
CytoBioscience, Inc. Medical SpecialtiesHealth Technology CytoBioscience, Inc. manufactures medical devices. It creates and manufactures devices that represent a convergence of bioscience, nano science, microchip development, algorithms and engineering. The firm offers CRO services. The company is headquartered in San Antonio, TX. | Health Technology |
InventaBiotech, Inc.
InventaBiotech, Inc. Miscellaneous Commercial ServicesCommercial Services InventaBiotech, Inc. operated as a marketing, media, and investor relations consultant to public and private companies. The company was founded on October 18, 2007 and was headquartered in San Antonio, TX. | Commercial Services |
Incyte Venture Partners LLC
Incyte Venture Partners LLC Investment ManagersFinance Incyte Venture Partners LLC (Incyte Venture Partners) is a venture capital firm founded in 2009. The firm is headquartered in San Antonio, Texas. | Finance |